Cannabis Law Report

OCTOBER 15, 2021

At ASHG, Goldfinch Bio will give an oral presentation showcasing insights revealed by its Kidney Genome Atlas (KGA). At ASHG, Goldfinch Bio will give an oral presentation showcasing insights revealed by its Kidney Genome Atlas (KGA). Both meetings are being held virtually. President and Chief Executive Officer of Goldfinch Bio.

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

Veriheal

JANUARY 11, 2023

Gaize is mastering the art of cannabis impairment detection. The Missoula, Montana-based company is gearing up for the launch of its first science-backed real-time cannabis impairment detection device. Studies on cannabis have shown that the plant may cause disorientation, sedation, lack of concentration, and impaired judgment.

Clinical Trials 98

Clinical Trials THC Data Safety 98

Cannabis Law Report

AUGUST 7, 2021

The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. The right candidate will have a passion for clinical research in novel therapeutics and a proven track record of regulatory affairs experience. Key Responsibilities.

Clinical Trials 105

Clinical Trials Research and Development Compliance Compliance 105

Veriheal

MARCH 20, 2023

Florida Florida presented two bills (SB 348 and HB 193). Illinois Illinois lawmakers presented a bill called the “Compassionate Use and Research of Entheogens Act.” Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. appeared first on Cannabis Central. Minnesota Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Canna Care Docs

JUNE 18, 2018

For those who might be exploring the benefits of cannabis or are considering its many therapeutic effects, Cannabidiol, often abbreviated as CBD is especially important for cannabis patients. CBD possess a wide array of therapeutic effects, without the psychoactive and intoxicating effects that are typically associated with cannabis.

Clinical Trials 75

Clinical Trials CBD Epilepsy Patients 75

CannaMD

JUNE 2, 2021

In a paper presented at the 2020 International Congress of Parkinson’s Disease and Movement Disorders , the authors reported on the results of an anonymous survey completed by more than 1,000 individuals living with Parkinson’s disease. Why Do Parkinson’s Patients Use Marijuana? The remainder reported partial or no relief.

Patients 105

Patients Clinical Trials Treatment Research and Development 105

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. Though, Oregon is actively in the process of establishing a model for psilocybin that would be like the state’s current medical cannabis system. Schedule I.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

OCTOBER 5, 2021

Management will deliver a company presentation on October 15 th at 3:25 p.m. Investors can register for the event here and view the live presentation here. is a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance addiction.

Pharmaceutical 40

Pharmaceutical Clinical Trials Cannabinoids Events 40

Cannabis Law Report

FEBRUARY 2, 2022

UK website Leafie writes… The findings of a study published in JAMA Psychiatry have revealed that road testing for cannabis impairment may be putting up to 1.4m medical cannabis users at risk of unfair prosecution, according to a report by Volteface. Further simulator tests were given at 30 minutes, 1.5, hours after smoking.

Medicine 52

Medicine Clinical Trials Consumption Sleep 52

Medicinal Marijuana Association

FEBRUARY 11, 2024

You may have heard whispers of cannabis being used to address a specific eye condition, but what does the research truly reveal about its effectiveness? The potential link between cannabis and glaucoma treatment is a topic of ongoing investigation, stirring both curiosity and caution within the medical community.

Treatment 52

Treatment Blood Pressure Conditions Clinical Trials 52

FloridaMarijuana.net

JUNE 13, 2018

For centuries, humans have relied on the cannabis plant for its therapeutic properties. More than ever, cannabis can aid in the treatment of chronic disease and as a supplement to cancer treatments. Cannabis has given cancer patients relief , improved their mood and anxiety, and relieved insomnia.

Clinical Trials 189

Clinical Trials Marijuana Patients Chronic Pain 189

The Joint Blog

JUNE 20, 2019

After seeing a huge improvement in Rosie’s quality of life, Blake launched Cannabis Supplements For Pets ; a website for pet owners covering the health benefits of CBD with reviews of leading CBD pet brands. He always includes his resources in his articles, which can include clinical trials, case studies, research papers, and more.

Pets 40

Pets Oil CBD Clinical Trials 40

Veriheal

JULY 16, 2020

The commission tasked with developing recommendations to improve mental health treatment for veterans concluded: Congress and the executive branch need to promote research into the therapeutic potential of cannabis and psychedelics such as psilocybin mushrooms and MDMA. The Commission Focused on Veteran Well-being. Veterans across the U.S.

Research and Development 95

Research and Development Clinical Trials Treatment Compliance 95

The Cannigma

FEBRUARY 2, 2021

This article was originally published on Analytical Cannabis and appears here with permission. . In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Of these consumers, over half said the drug had a beneficial clinical effect on their condition.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

MARCH 12, 2020

They write… The Psychedelics as Medicine Report presents unparalleled insights and intelligence into this emerging movement, helping to guide investors, operators and regulators through this transient phase. Download your free copy now.

Medicine 59

Medicine Clinical Trials Therapy Events 59

PrestoDoctor

SEPTEMBER 15, 2023

However, recent research suggests that cannabis may be a promising option for those seeking relief from OCD symptoms. We’ll explore the ways in which cannabis can help ease OCD symptoms and compulsions and how to use it effectively. We’ll also examine the potential benefits and drawbacks of using cannabis to manage OCD.

Research and Development 105

Research and Development Therapy Treatment Strains 105

Cannabis Law Report

OCTOBER 2, 2021

The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. The right candidate will have a passion for clinical research in novel therapeutics and a proven track record of regulatory affairs experience. Key Responsibilities.

Clinical Trials 52

Clinical Trials Research and Development Compliance Compliance 52

Cannabis Law Report

JUNE 11, 2021

This chief executive officer transition is a natural progression for MindMed as the Company heads into later stage clinical trials. Our work to date and ability to raise capital has taken us leaps and bounds closer to that vision. This all could not have been possible without you.”.

Clinical Trials 95

Clinical Trials Research and Development Pharmaceutical Medicine 95

The Cannigma

MARCH 7, 2022

Yet cannabinol (CBN), the first cannabinoid ever discovered by modern scientists, is slowly making a comeback in the cannabis industry. . Of course, this plant is now known to be marijuana (or Type I cannabis), which is still commonly used for sleep and analgesia today. The best online schools for medical cannabis training.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

NewsMunchies

AUGUST 25, 2021

The scientific evidence around CBD use is thin due to the fact that cannabis is a Schedule 1 drug, which limits the research needed to figure out how best to use it. The clinical trial literature tracking CBD’s effectiveness is quite limited. Under the U.S. We know this, too, because CBD is creating sky-high profits.

CBD 98

CBD Chronic Pain Clinical Trials Oil 98

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. MAPS PBC is a Public Benefit Corporation, with a dual mandate to generate shareholder value and public benefit. Key Responsibilities.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

Project CBD

AUGUST 6, 2019

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. THC was present in 89 percent of the samples, but in most cases no amount of THC was provided.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. For more information, visit the company’s website or download their investor presentation. Mental Health Challenges. Disclaimer.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

NOVEMBER 23, 2021

COMP360 has been designated a Breakthrough Therapy by the US Food and Drug Administration (FDA), for treatment-resistant depression (TRD), and we have completed a phase IIb clinical trial of psilocybin therapy for TRD, in 22 sites across Europe and North America.

Clinical Trials 52

Clinical Trials Therapy Research and Development Media 52

Cannabis Law Report

MARCH 1, 2022

Contribute to the production of project-related documents, budgets, presentations, patents and regulatory submissions as required. Knowledge of Canadian, Australian and New Zealand clinical trial regulations and procedures is a plus. Outstanding written and verbal communication and presentation skills. Qualifications.

Clinical Trials 52

Clinical Trials Environment Pharmaceutical Programs 52

Otherside Farms

JANUARY 25, 2019

Lead author Dr. Tim England, honorary consultant stroke physician at the University of Nottingham and Royal Derby Hospital, presented the findings at this week’s annual UK Stroke Forum conference. The data are guiding the next steps in experimental stroke in order to be able to progress onto initial safety assessments in a clinical trial.”.

Clinical Trials 74

Clinical Trials Marijuana Cannabinoids Data 74

Cannabis Law Report

AUGUST 12, 2021

Phase IIb clinical trial of COMP360 psilocybin therapy for TRD close to completion. Business highlights. COMP360 psilocybin therapy has now been given to 233 patients, exceeding 216 target. On track to report top-line data by end of 2021. We are headquartered in London, UK, with offices in New York, US.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

OCTOBER 5, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it will present at the Benzinga Rising Stars: Catalytic Small Cap Growth Conference on Thursday, October 7, 2021. The Company’s presentation will be available for viewing that day at 10:10 a.m.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Media 52

The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. People want to trust their doctors, but doctors need knowledge. We have a ways to go,” Tan said.

Education 101

Education Clinical Trials Medicine Policy 101

SpeedWeed

AUGUST 16, 2021

LAS VEGAS, NV [August 16, 2021] – Cannabis Conference , produced by parent company GIE Media Inc. Dr. Sisley will highlight cutting-edge discoveries from her roles in cannabis studies for pain management and post-traumatic stress disorder (PTSD), as a substitution therapy for opioids, and more. About Cannabis Conference.

Media 52

Media Clinical Trials DEA Hemp 52

Cannabis Law Report

DECEMBER 21, 2021

CBG or cannabigerol is obtained from immature cannabis plants since it is not present in fully developed plants. While obtaining CBG was a difficult process earlier on, cannabis growers have now hybridized the hemp plant and created strains that are now CBG dominant at maturity. The Potential Benefits of CBG.

Conditions 52

Conditions Research and Development Clinical Trials Oil 52

Project CBD

AUGUST 6, 2019

Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data. Related story Can CBD Help Your Condition? Preclinical promise. CBD for stroke.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Cannabis Law Report

JULY 24, 2021

The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

OCTOBER 2, 2021

Contribute to the production of project-related documents, budgets, presentations, patents and regulatory submissions as required. Knowledge of Canadian, Australian and New Zealand clinical trial regulations and procedures is a plus. Outstanding written and verbal communication and presentation skills. Qualifications.

Clinical Trials 52

Clinical Trials Environment Pharmaceutical Programs 52

Cannabis Law Report

JUNE 8, 2021

This SRA will leverage four other clinical trials being planned by the university, to determine the effects of psilocybin on inflammatory markers of patients who have exhibited Parkinson’s, Bipolar disorder, and chronic back pain. Investor Relations Contact: Hayden IR.

Patients 92

Patients Research and Development Clinical Trials Chronic Pain 92

Puff Puff Post

OCTOBER 3, 2019

Montefiore Medical Center in New York and GW Pharmaceuticals are examining the effects of a cannabis compound when administered to children on the autism spectrum. The cannabis compound referred to as cannabidivarin (CBDV) is a non-psychoactive chemical that does not cause a “high” when consumed.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

Cannabis Law Report

JULY 30, 2019

Cannabis-based products will be allowed to bypass usual processes required for medicines in New Zealand and go directly onto the market without any proof of safety or effectiveness. This unprecedented proposal is contained in the government’s consultation document on giving greater access to medicinal cannabis.

Medicine 40

Medicine Clinical Trials Safety Access 40